Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials

Drug Discovery Today

Volumn 18, Issue 3-4, 2013, Pages 128-140

  Mimeault, Murielle ^a   Batra, Surinder K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANTINEOPLASTIC AGENT; CD133 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; ENHANCED GREEN FLUORESCENT PROTEIN; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; MAFOSFAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYOGENIN; NANOMATERIAL; OCTAMER TRANSCRIPTION FACTOR 4; RETINOIC ACID; ROSUVASTATIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR NANOG; VINCRISTINE;

BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL FUNCTION; CELL INVASION; CELL SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IN VIVO STUDY; LEUKEMIA; METASTASIS; NONHUMAN; PANCREAS ADENOCARCINOMA; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SOMATIC MUTATION; TUMOR MICROENVIRONMENT; TUMOR MODEL; XENOTRANSPLANTATION; ZEBRA FISH;

ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; HUMANS; NANOSTRUCTURES; NEOPLASMS; ZEBRAFISH;

EID: 84873091649     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.08.002     Document Type: Review

References (128)

1. T.P. Barros Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery Br. J. Pharmacol. 154 2008 1400 1413
2. E.T. Keller, and J.M. Murtha The use of mature zebrafish (Danio rerio) as a model for human aging and disease Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 138 2004 335 341
3. A.C. Smith High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia Blood 115 2010 3296 3303
4. E.E. Patton BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma Curr. Biol. 15 2005 249 254
5. S.W. Park Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas Gastroenterology 134 2008 2080 2090
6. I.J. Marques Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model BMC Cancer 9 2009 128
7. A. Eguiara Xenografts in zebrafish embryos as a rapid functional assay for breast cancer stem-like cell identification Cell Cycle 10 2011 3751 3757
8. A.T. Nguyen An inducible krasV12 transgenic zebrafish model for liver tumorigenesis and chemical drug screening Dis. Model Mech. 5 2012 63 72
9. L.I. Zon, and R.T. Peterson In vivo drug discovery in the zebrafish Nat. Rev. Drug Discov. 4 2005 35 44
10. G.F. Gerlach Dissection of the adult zebrafish kidney J. Vis. Exp. 29 2011 2839
11. E.A. Ober From endoderm formation to liver and pancreas development in zebrafish Mech. Dev. 120 2003 5 18
12. H.E. Sabaawy TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia Proc. Natl. Acad. Sci. U. S. A. 103 2006 15166 15171
13. L.A. Rudner Shared acquired genomic changes in zebrafish and human T-ALL Oncogene 30 2011 4289 4296
14. D.M. Langenau Myc-induced T cell leukemia in transgenic zebrafish Science 299 2003 887 890
15. D.M. Langenau Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia Proc. Natl. Acad. Sci. U. S. A. 102 2005 6068 6073
16. D.M. Langenau Effects of RAS on the genesis of embryonal rhabdomyosarcoma Genes Dev. 21 2007 1382 1395
17. I.H. Jung Aberrant hedgehog ligands induce progressive pancreatic fibrosis by paracrine activation of myofibroblasts and ductular cells in transgenic zebrafish PLoS ONE 6 2011 E27941
18. S.L. Lee Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model Proc. Natl. Acad. Sci. U. S. A. 106 2009 19485 19490
19. E.E. Patton, and L.I. Zon The art and design of genetic screens: zebrafish Nat. Rev. Genet. 2 2001 956 966
20. E. Wiellette Combined haploid and insertional mutation screen in the zebrafish Genesis 40 2004 231 240
21. A. Amsterdam Zebrafish Hagoromo mutants up-regulate fgf8 postembryonically and develop neuroblastoma Mol. Cancer Res. 7 2009 841 850
22. K. Lai Many ribosomal protein mutations are associated with growth impairment and tumor predisposition in zebrafish Dev. Dyn. 238 2009 76 85
23. Z. Li Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish J. Hepatol. 56 2012 419 425
24. J.C. Neumann Zebrafish models of germ cell tumor Methods Cell Biol. 105 2011 3 24
25. A. Gutierrez Aberrant AKT activation drives well-differentiated liposarcoma Proc. Natl. Acad. Sci. U. S. A. 108 2011 16386 16391
26. N.A. Liu Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor Proc. Natl. Acad. Sci. U. S. A. 108 2011 8414 8419
27. M.S. Ignatius In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma Cancer Cell 21 2012 680 693
28. I.V. Mizgireuv, and S.Y. Revskoy Transplantable tumor lines generated in clonal zebrafish Cancer Res. 66 2006 3120 3125
29. M. Haldi Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish Angiogenesis 9 2006 139 151
30. K. Stoletov Visualizing extravasation dynamics of metastatic tumor cells J. Cell Sci. 123 2010 2332 2341
31. C. Zhao A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors PLoS ONE 6 2011 E21768
32. C. Zhao Distinct contributions of angiogenesis and vascular co-option during the initiation of primary microtumors and micrometastases Carcinogenesis 32 2011 1143 1150
33. S. Kim Modular, easy-to-assemble, low-cost zebrafish facility Zebrafish 6 2009 269 274
34. S.H. Lam Development and maturation of the immune system in zebrafish, Danio rerio: a gene expression profiling, in situ hybridization and immunological study Dev. Comp. Immunol. 28 2004 9 28
35. R. Harfouche Nanoparticle-mediated targeting of phosphatidylinositol-3- kinase signaling inhibits angiogenesis Angiogenesis 12 2009 325 338
36. B. Liu Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis Oncogene 26 2007 1811 1819
37. B. Pruvot Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy Haematologica 96 2011 612 616
38. I.V. Mizgirev, and S. Revskoy A new zebrafish model for experimental leukemia therapy Cancer Biol. Ther. 9 2010 895 902
39. B.E. Lally Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical library Cancer Res. 67 2007 8791 8799
40. F.U. Weiss Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer Gastroenterology 137 2009 2136 2145
41. A.M. Forrester NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis Br. J. Haematol. 155 2011 167 181
42. L.L. Vollmer A simplified synthesis of novel dictyostatin analogues with in vitro activity against epothilone B-resistant cells and antiangiogenic activity in zebrafish embryos Mol. Cancer Ther. 10 2011 994 1006
43. D.H. Vlecken, and C.P. Bagowski LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells Zebrafish 6 2009 433 439
44. E. Pluskota The integrin coactivator kindlin-2 plays a critical role in angiogenesis in mice and zebrafish Blood 117 2011 4978 4987
45. E.Y. Lukianova-Hleb Generation and detection of plasmonic nanobubbles in zebrafish Nanotechnology 21 2010 225102
46. A. Latifi Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile J. Cell. Biochem. 112 2011 2850 2864
47. J.L. Shepard A mutation in separase causes genome instability and increased susceptibility to epithelial cancer Genes Dev. 21 2007 55 59
48. A. Gutierrez Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia J. Exp. Med. 208 2011 1595 1603
49. J.H. Postlethwait Zebrafish comparative genomics and the origins of vertebrate chromosomes Genome Res. 10 2000 1890 1902
50. I.G. Woods A comparative map of the zebrafish genome Genome Res. 10 2000 1903 1914
51. A. Menuet Molecular characterization of three estrogen receptor forms in zebrafish: binding characteristics, transactivation properties, and tissue distributions Biol. Reprod. 66 2002 1881 1892
52. C. Stuckenholz FACS-assisted microarray profiling implicates novel genes and pathways in zebrafish gastrointestinal tract development Gastroenterology 137 2009 1321 1332
53. N.D. Lawson, and B.M. Weinstein Arteries and veins: making a difference with zebrafish Nat. Rev. Genet. 3 2002 674 682
54. C.T. Fu An evolutionarily conserved PTEN-C/EBPalpha-CTNNA1 axis controls myeloid development and transformation Blood 115 2010 4715 4724
55. S. Nicoli Mammalian tumor xenografts induce neovascularization in zebrafish embryos Cancer Res. 67 2007 2927 2931
56. J. Heasman Morpholino oligos: making sense of antisense? Dev. Biol. 243 2002 209 214
57. H. Feitsma, and E. Cuppen Zebrafish as a cancer model Mol. Cancer Res. 6 2008 685 694
58. S. Berghmans tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors Proc. Natl. Acad. Sci. U. S. A. 102 2005 407 412
59. A.P. Haramis Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia EMB Rep. 7 2006 444 449
60. A. Amsterdam Many ribosomal protein genes are cancer genes in zebrafish PLoS Biol. 2 2004 E139
61. J. Lin Progenitor expansion in apc mutants is mediated by Jak/Stat signaling BMC Dev. Biol. 11 2011 73
62. Y. Doyon Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases Nat. Biotechnol. 26 2008 702 708
63. X. Meng Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases Nat. Biotechnol. 26 2008 695 701
64. R. Thummel Cre-mediated site-specific recombination in zebrafish embryos Dev. Dyn. 233 2005 1366 1377
65. X. Le Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish Proc. Natl. Acad. Sci. U. S. A. 104 2007 9410 9415
66. H. Feng Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/lox-regulated transgenic zebrafish Br. J. Haematol. 138 2007 169 175
67. L.M. Lee The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation Dev. Dyn. 233 2005 1560 1570
68. L. Dumartin AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D Cancer Res. 71 2011 7091 7102
69. P. Rouhi Hypoxia-induced metastasis model in embryonic zebrafish Nat. Protoc. 5 2010 1911 1918
70. L. Zhang An optical platform for cell tracking in adult zebrafish Cytometry A 81 2012 176 182
71. R.M. White Transparent adult zebrafish as a tool for in vivo transplantation analysis Cell Stem Cell 2 2008 183 189
72. J.S. Blackburn Quantifying the frequency of tumor-propagating cells using limiting dilution cell transplantation in syngeneic zebrafish J. Vis. Exp. 53 2011 E2790
73. A.O. Benyumov Anti-proliferative and anti-leukemic activity of DDE46 (compound WHI-07), a novel bromomethoxylated arylphosphate derivative of zidovudine, and related compounds Studies using human acute lymphoblastic leukemia cells and the zebrafish model Arzneimittelforschung 55 2005 114 122
74. J.R. Yeh Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation Nat. Chem. Biol. 5 2009 236 243
75. E.A. Murphy Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF Proc. Natl. Acad. Sci. U. S. A. 107 2010 4299 4304
76. C. Wang Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer Eur. Urol. 58 2010 418 426
77. C. Sachidanandan Identification of a novel retinoid by small molecule screening with zebrafish embryos PLoS ONE 3 2008 E1947
78. O. Bar-Ilan Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos Small 5 2009 1897 1910
79. R.M. White DHODH modulates transcriptional elongation in the neural crest and melanoma Nature 471 2011 518 522
80. C. Zhang Zebrafish: an animal model for toxicological studies Current Protocols in Toxicology 2003 John Wiley & Sons New York, NY, U.S.A. Unit 1.7, 1-18
81. G. Kari Zebrafish: an emerging model system for human disease and drug discovery Clin. Pharmacol. Ther. 82 2007 70 80
82. D.S. Wagner The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts Biomaterials 31 2010 7567 7574
83. G.A. Geiger Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system Cancer Res. 68 2008 3396 3404
84. B. Daroczi In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model Clin. Cancer Res. 12 2006 7086 7091
85. B. Daroczi Nuclear factor kappaB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos Mol. Cancer Ther. 8 2009 2625 2634
86. M. Head, and M.B. Jameson The development of the tumor vascular-disrupting agent ASA404 (vadimezan DMXAA): current status and future opportunities Expert Opin. Investig. Drugs 19 2010 295 304
87. B. Ghosh Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation ACS Chem. Biol. 4 2009 367 377
88. C.H. Pui Acute lymphoblastic leukemia N. Engl. J. Med. 350 2004 1535 1548
89. M.L. Kalev-Zylinska Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis Development 129 2002 2015 2030
90. S.M. Onnebo Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion Exp. Hematol. 33 2005 182 188
91. B. Lutterbach, and S.W. Hiebert Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation Gene 245 2000 223 235
92. J.M. Goldberg Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience J. Clin. Oncol. 21 2003 3616 3622
93. R. Bassan Adult acute lymphoblastic leukaemia Crit. Rev. Oncol. Hematol. 50 2004 223 261
94. H. Tsao Management of cutaneous melanoma N. Engl. J. Med. 351 2004 998 1012
95. C. Garbe, and U. Leiter Melanoma epidemiology and trends Clin. Dermatol. 27 2009 3 9
96. R. Siegel Cancer statistics, 2012 CA Cancer J. Clin. 62 2012 10 29
97. A.B. Francken Follow-up in patients with localised primary cutaneous melanoma Lancet Oncol. 6 2005 608 621
98. H.A. Tawbi, and S.C. Buch Chemotherapy resistance abrogation in metastatic melanoma Clin. Adv. Hematol. Oncol. 8 2010 259 266
99. I.F. Tannock Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N. Engl. J. Med. 351 2004 1502 1512
100. D.P. Petrylak Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer N. Engl. J. Med. 351 2004 1513 1520
101. M. Mimeault, and S.K. Batra Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies Carcinogenesis 27 2006 1 22
102. G.P. Haas The worldwide epidemiology of prostate cancer: perspectives from autopsy studies Can. J. Urol. 15 2008 3866 3871
103. M. Mimeault, and S.K. Batra Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and novel promising multitargeted therapies Mol. Med. 17 2011 649 664
104. S.J. Freedland Screening, risk assessment, and the approach to therapy in patients with prostate cancer Cancer 117 2010 1123 1135
105. M. Mimeault, and S.K. Batra Animal models of prostate carcinogenesis underlining the critical implication of prostatic stem progenitor cells Biochim. Biophys. Acta 1816 2011 25 37
106. M. Mimeault Pathobiological implications of the expression of EGFR, pAkt, NF-kB and MIC-1 in prostate cancer stem cells and their progenies PLoS ONE 7 2012 E31919
107. M. Mimeault Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and non-side population cell fractions from human invasive prostate cancer cells Mol. Cancer Ther. 9 2010 617 630
108. R.U. Lukacs Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation Cell Stem Cell 7 2010 682 693
109. N. Bansal Targeting Bmi1 in human prostate tumor initiating cells AACR Meeting Abstracts 2010 4279
110. T. Sorlie Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms BMC Genomics 7 2006 127
111. M. Guedj A refined molecular taxonomy of breast cancer Oncogene 31 2011 1196 1206
112. C.L. Arteaga Treatment of HER2-positive breast cancer: current status and future perspectives Nat. Rev. Clin. Oncol. 9 2012 16 32
113. R.S. Punglia Local therapy and survival in breast cancer N. Engl. J. Med. 356 2007 2399 2405
114. K. Stoletov High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish Proc. Natl. Acad. Sci. U. S. A. 104 2007 17406 17411
115. K. Stoletov, and R. Klemke Catch of the day: zebrafish as a human cancer model Oncogene 27 2008 4509 4520
116. B. Jelassi P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness Oncogene 30 2011 2108 2122
117. R.E. Brand Advances in counselling and surveillance of patients at risk for pancreatic cancer Gut 56 2007 1460 1469
118. M. Hidalgo Pancreatic cancer N. Engl. J. Med. 362 2010 1605 1617
119. M. Di Marco Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? Oncol. Rep. 23 2010 1183 1192 (review)
120. M. Mimeault Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies Pancreas 31 2005 301 316
121. M. Mimeault, and S.K. Batra Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer Gut 57 2008 1456 1468
122. T. Kamisawa Long-term follow-up of chronic pancreatitis patients with K-ras mutation in the pancreatic juice Hepatogastroenterology 58 2011 174 176
123. Z. Ji Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells J. Biol. Chem. 282 2007 14048 14055
124. A. Maitra, and R.H. Hruban Pancreatic cancer Annu. Rev. Pathol. 3 2008 157 188
125. 2+-sensitive Socs3a signaling in development and cancer Dis. Model Mech. 4 2011 240 254
126. W. Zhou Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer Cancer Biol. Ther. 11 2011 659 670
127. O.A. Kent Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway Genes Dev. 24 2010 2754 2759
128. N.B. Prasad Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells Cancer Res. 65 2005 1619 1626